Document is current
Any future updates will be listed below
-
Authors
Haas, Daniel T.
Weindl, Daniel https://orcid.org/0000-0001-9963-6057
Kakimoto, Pamela
Trautmann, Eva-Maria https://orcid.org/0009-0002-0691-0489
Schessner, Julia P.
Mao, Xia
Gerl, Mathias J. https://orcid.org/0000-0002-8074-7221
Gerwien, Maximilian
Müller, Timo D.
Klose, Christian
Cheng, Xiping
Hasenauer, Jan https://orcid.org/0000-0002-4935-3312
Krahmer, Natalie https://orcid.org/0000-0003-4063-7367
- License Information
-
More Information
Article History
Received: 8 October 2024
Accepted: 21 September 2025
First Online: 4 December 2025
Change Date: 28 January 2026
Change Type: Update
Change Details: In the version of the article initially published, the wrong city was included in affiliation 2 which has now been amended to “German Center for Diabetes Research (DZD), Neuherberg, Germany” in the HTML and PDF versions of the article.
Competing interests
: T.D.M. receives research funding by Novo Nordisk and has received speaking fees from Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Merck, AstraZeneca and Mercodia. All other authors declare no competing interests.
